norovirus principal caps spider gastroenter worldwide ii strain account infect major caps protein evolve rapidly result new alter antigen potent test drift may contribute persist human memory b cell import monoclonal antibody mab character reactive panel timed viruslik partial lp reflect complex exposure history volume antigen group three lp pattern ancestry contemporary broad nb react excess earliest eia blocked specify bound block nb variant mineral strain two also detect genogroup ii block interact carbohydr ligand crossneutr measure vlpcarbohydr assay use mutant design alter predict editor giispecif map amino acid require bind essential support earlier correct antibody escape variant data inform vaccine design provide strategy expand crossblockad potent chime vaccine identify broadly neutral therapeutic treatment disease more support hypothesis noroviru revolt heavily influence consent antibodydriven receptor switch thu protect herd immune drive for molecular 